flavocoxid

DIETARY_SUPPLEMENT4 trials

Sponsors

University of Alabama at Birmingham, Primus Pharmaceuticals, University of Messina

Conditions

Duchenne Muscular DystrophyOsteoarthritisOsteoarthritis of Knee

Phase 1

Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis

CompletedNCT00294125

University of Alabama at BirminghamOsteoarthritis

Start: 2006-02-28End: 2007-11-30Updated: 2013-04-22

Safety Study of Flavocoxid in Duchenne Muscular Dystrophy

CompletedNCT01335295

University of MessinaDuchenne Muscular Dystrophy

Start: 2011-03-31End: 2013-12-31Updated: 2014-02-03

Unknown Phase

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

CompletedNCT00303017

Primus PharmaceuticalsOsteoarthritis

Start: 2006-03-31End: 2006-09-30Updated: 2015-10-21

Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee

CompletedNCT00790985

Primus PharmaceuticalsOsteoarthritis of Knee

Start: 2008-01-31End: 2008-08-31Updated: 2022-11-01